Deriglidole

CAS No. 122830-14-2

Deriglidole( —— )

Catalog No. M32880 CAS No. 122830-14-2

Deriglidole (SL 86-0715) is a peripheral adrenergic receptor antagonist that is a selective inhibitor of alpha2 receptors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 699 Get Quote
5MG 1007 Get Quote
10MG 1349 Get Quote
25MG 1932 Get Quote
50MG 2374 Get Quote
100MG 3060 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Deriglidole
  • Note
    Research use only, not for human use.
  • Brief Description
    Deriglidole (SL 86-0715) is a peripheral adrenergic receptor antagonist that is a selective inhibitor of alpha2 receptors.
  • Description
    Deriglidole is a peripheral adrenoceptor antagonist with a high affinity for α2-adrenoceptors.
  • In Vitro
    Deriglidole is a selective α2-receptor inhibitor. Deriglidole inhibits [3H]Clonidine and [3H]Idazoxan but not [3H]Prazosin binding to rat cortical and human platelet α2-adrenoceptors and is more selective than Idazoxan for peripheral receptors.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    122830-14-2
  • Formula Weight
    255.36
  • Molecular Formula
    C16H21N3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CC)C1(N2C=3C(C1)=CC=CC3CC2)C=4NCCN4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Natali A,et al. Effects of acute alpha 2-blockade on insulin action and secretion in humans. Am J Physiol. 1998 Jan;274(1 Pt 1):E57-64.?
molnova catalog
related products
  • Imiloxan

    Imiloxan (RS-21361) is an α2 adrenergic receptor antagonist used in the treatment of major depressive disorder.

  • Bucumolol

    Bucumolol (Bucumarol) is a β-adrenergic blocking agent and a local anesthetic with antihypertensive activity and can be used to study myocardial infarction.

  • (±)-Prenalterol

    (±)-Prenalterol (H 80/62) is a new cardioselective positive inotropic compound that is an agonist of beta-2- and beta-1-adrenergic receptors and can be used to study chronic congestive heart failure.